An experimental breast cancer treatment co-developed by Pfizer and Arvinas significantly improved the time some patients ...

Senators question Pfizer's partnership with UpScriptHealth, citing potential anti-kickback concerns and risks of increased ...

Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

Pfizer (NYSE:PFE) stock and Arvinas (NASDAQ:ARVN) stock slip in reaction to mixed Phase 3 data for their breast cancer drug ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

Senators ask if contracts between drugmakers and telehealth companies violate the federal anti-kickback statute.

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Lane. Pfizer has deemed the property surplus and has offered to sell it to the city for $1.00. It is recommended that City ...